In pursuit of prodromal Parkinson's disease

The Lancet Neurology

Volumn 14, Issue 1, 2015, Pages 27-28

  Lang, Anthony E ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b TORONTO WESTERN HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FEMALE; HUMAN; MALE; PARKINSON DISEASE; PATHOPHYSIOLOGY; PRIMARY HEALTH CARE; PRODROMAL SYMPTOM; STATISTICS AND NUMERICAL DATA;

FEMALE; HUMANS; MALE; PARKINSON DISEASE; PRIMARY HEALTH CARE; PRODROMAL SYMPTOMS;

EID: 84918529191     PISSN: 14744422     EISSN: 14744465     Source Type: Journal    
DOI: 10.1016/S1474-4422(14)70230-3     Document Type: Note

References (13)

1. Schrag A, Horsfall L, Walters K, Noyce A, Petersen I Prediagnostic presentations of Parkinson's disease in primary care: a case-control study. Lancet Neurol 2014, published online Nov 27. http://dx.doi.org/10.1016/S1474-4422(14)70287-X.
2. Aldakheel A, Kalia LV, Lang AE Pathogenesis-targeted, disease-modifying therapies in Parkinson disease. Neurotherapeutics 2014, 11:6-23.
3. Lang AE Clinical trials of disease-modifying therapies for neurodegenerative diseases: the challenges and the future. Nature Med 2010, 16:1223-1226.
4. Bernheimer H, Birkmayer W, Hornykiewicz, Jellinger K, Seitelberger F Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. J Neurol Sci 1973, 20:415-455.
5. Braak H, Tredici KD, Rub U, De Vos RA, Jansen Steur EN, Braak E Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003, 24:197-211.
6. Berg D, Lang AE, Postuma RB, et al. Changing the research criteria for the diagnosis of Parkinson's disease: obstacles and opportunities. Lancet Neurol 2013, 12:514-524.
7. Berg D, Postuma RB, Bloem B, et al. Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson's disease. Mov Disord 2014, 29:454-462.
8. Abbott RD, Petrovitch H, White LR, et al. Frequency of bowel movements and the future risk of Parkinson's disease. Neurology 2001, 57:456-462.
9. Shiba M, Bower JH, Maraganore DM, et al. Anxiety disorders and depressive disorders preceding Parkinson's disease: a case-control study. Mov Disord 2000, 15:669-677.
10. Adler CH, Beach TG, Hentz JG, et al. Low clinical diagnostic accuracy of early vs advanced Parkinson disease: clinicopathologic study. Neurology 2014, 83:406-412.
11. Ross GW, Petrovitch H, Abbott RD, et al. Association of olfactory dysfunction with risk for future Parkinson's disease. Ann Neurol 2008, 63:167-173.
12. Postuma RB, Gagnon JF, Vendette M, Fantini ML, Massicotte-Marquez J, Montplaisir J Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder. Neurology 2009, 72:1296-1300.
13. Bonifati V Genetics of Parkinson's disease-state of the art, 2013. Parkinsonism Relat Disord 2014, 20(suppl 1):S23-S28.